Amphastar Pharmaceuticals (29A.F) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.36
0.51
0.66
0.81

Details

Expected EPS
0.6012321123900001
Actual EPS
0.3581214
Surprise EPS
-0.24
Surprise Percent
+40.44%

Description

Amphastar Pharmaceuticals (29A.F) has reported earnings of 0.3581214 per share for Q2 2026.

0 Comments

Share your thoughts